# RANOLAZINE
> **ANDA212930** · Abbreviated New Drug Application (Generic) · Sponsor: ACCORD HLTHCARE · Approved 2021-05-18
## Drug
- **FDA Application Number:** ANDA212930
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RANOLAZINE
- **Generic name:** Ranolazine
- **Active ingredients:** RANOLAZINE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ACCORD HLTHCARE
- **First approval:** 2021-05-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212930)
---
*MORVS · CC0 1.0*